72 Results for "

HT-29cell

" in MedChemExpress (MCE) Product Catalog:
Products (72)

72 Results for "HT-29cell" in MCE Product Catalog:

Cat. No.: HY-157963
CAS No.: 3031534-16-1
Target:  

RIP kinase Necroptosis

Research Areas:  

Inflammation/Immunology Cancer

RIPK1-IN-23 (compound 19) is a RIPK1 inhibitor with potent anti-necroptotic effects in HT-29 cells (EC50 of 1.7 nM). RIPK1-IN-23 shows anti-inflammatory activities .
loading...
    loading...
Cat. No.: HY-115949
CAS No.: 2917547-24-9
Target:  

HSP

Research Areas:  

Cancer

Antitumor agent-47 (Compound 3e) is a silibinin derivative with an antitumor activity. Antitumor agent-47 shows cytotoxic activity against NCI-H1299 and HT29 cells with IC50 values of 8.07 µM and 6.27 µM, respectively .
loading...
    loading...
Cat. No.: HY-173445
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

RIPK1-IN-30 (compound 24) is a potent RIPK1 inhibitor with an IC50 of 2.01 μM. RIPK1-IN-30 exhibits protective effects in HT-29 cell model of TSZ-induced necroptosis with an EC50 of 6.77 μM .
loading...
    loading...
Cat. No.: HY-173227
CAS No.: 1877313-32-0
Target:  

Trk Receptor

Research Areas:  

Cancer

TrkC-IN-1 (Compound 6c) is an inhibitor of TrkC. The IC50 values for EBC-1 and HT-29 cells are 3.3-7.1 and 7.3-10.2 μΜ, respectively. TrkC-IN-1 is expected to be used in the research of the anti-cancer field .
loading...
    loading...
Cat. No.: HY-N8387
CAS No.: 23665-96-5
Neogrifolin is an inhibitor of KRAS. Neogrifolin suppress KRAS expression in human colon cancer cells. Neogrifolin has anti-cell viability activity against HeLa, SW480 and HT29 cells wih IC50s of 24.3, 34.6, and 30.1 μM, respectively .
loading...
    loading...
Cat. No.: HY-N8462
CAS No.: 1206805-30-2
Synonyms: Scutebatin C
6-O-Nicotinoylscutebarbatine G is an alkaloid that can be isolated from Scutellaria barbata.6-O-Nicotinoylscutebarbatine has cytotoxic activities against HONE-1, KB and HT29 cells with IC50s of 3.1, 2.1 and 5.7 μM, respectively .
loading...
    loading...
Cat. No.: HY-147725
CAS No.: 2411962-64-4
Target:  

Microtubule/Tubulin

Research Areas:  

Cancer

Microtubule inhibitor 4 (compound 2) is a potent microtubule inhibitor. Microtubule inhibitor 4 shows cytotoxicity with IC50s of 4.0, 3.2, 2.1 nM for NCI-H460, BxPC-3, HT-29 cells, respectively. Microtubule inhibitor 4 shows the inhibition of tubulin polymerization .
loading...
    loading...
Cat. No.: HY-147727
CAS No.: 2416338-64-0
Target:  

Microtubule/Tubulin

Research Areas:  

Cancer

Microtubule inhibitor 6 (compound 17o) is a potent microtubule inhibitor. Microtubule inhibitor 6 shows cytotoxicity with IC50s of 14.0, 6.6, 7.0 nM for NCI-H460, BxPC-3, HT-29 cells, respectively. Microtubule inhibitor 6 efficiently inhibits microtubule polymerization .
loading...
    loading...
Cat. No.: HY-163806
CAS No.: 2820208-97-5
Target:  

HDAC

Research Areas:  

Neurological Disease Cancer

NT376 is a high potency and selectivity inhibitor of class-IIa Histone deacetylases (HDAC) with an IC50 value of 32 nM, similar to NT160 (HY-149285) (IC50= 46 nM) in HT-29 cells. NT376 is proming for research of various cancers and in the diseases of the central nervous system (CNS) such as Alzheimer’s and Huntington’s diseases .
loading...
    loading...
Cat. No.: HY-N14415
CAS No.: 134769-19-0
Cochleamycin A showed strong inhibitory activity against tumor cells, with IC50s (μg/mL) of P388, HL60, K562, COL0205 and HT29 cells of 1.6, 14.0, 6.2, 16.5 and 19.1, respectively. Cochleamycin A also has anti-Gram-positive bacteria activity .
loading...
    loading...
Cat. No.: HY-12855
CAS No.: 1391426-22-4
Target:  

Autophagy

Research Areas:  

Cancer

Lys01, a dimeric form of Chloroquine (HY-17589A), is an autophagy inhibitor. Lys01 inhibits cell viability of 1205Lu, c8161, LN229, HT-29 cells with IC50s of 3.6, 3.8, 7.9, 6.0 μM. Lys01 can be used for anticancer research .
loading...
    loading...
Cat. No.: HY-13734R
CAS No.: 141400-58-0
Synonyms: IV-2 (Standard)
Research Areas:  

Cancer

PX-12 (Standard) is the analytical standard of PX-12. This product is intended for research and analytical applications. PX-12(IV-2) is an irreversible inhibitor of Thioredoxin-1 (Trx-1); inhibits the growth of MCF-7 and HT-29 cells with IC50 values of 1.9 and 2.9 μM, respectively.
loading...
    loading...
Cat. No.: HY-178417
CAS No.: 2732914-43-9
Research Areas:  

Cancer

Angustilongine M is a microtubule-targeting antitumor alkaloid (IC50=0.2 μM against HT-29 cells). Angustilongine M induces G0/G1 cell cycle arrest and mitochondrial apoptosis via tubulin polymerization promotion. Angustilongine M is promising for research of colorectal cancer and other solid tumors .
loading...
    loading...
Cat. No.: HY-115950
CAS No.: 2917547-29-4
Target:  

Drug Derivative

Research Areas:  

Cancer

Antitumor agent-48 (Compound 4a) is a 2,3-dehydrosilybin derivative with an antitumor activity. Antitumor agent-48 shows cytotoxic activity against MCF-7, NCI-H1299, HepG2 and HT29 cells with IC50 values of 8.06 µM, 13.1 µM, 16.51 µM and 12.44 µM, respectively .
loading...
    loading...
Cat. No.: HY-161282
Target:  

Carbonic Anhydrase

Research Areas:  

Neurological Disease Cancer

hCAII-IN-10 (compound 11d) is hCA II inhibitor with the IC50s of 14 nM and 29.2 μM for hCA II and hCA I, respectively. hCAII-IN-10 inhibits cell growth against HT-29 cells with the IC50 of 74 μM. hCAII-IN-10 shows strongly lowered intraocular pressure in the glaucomatous rabbit eye model .
loading...
    loading...
Cat. No.: HY-163390
CAS No.: 3040025-57-5
Target:  

RIP kinase Necroptosis

Research Areas:  

Inflammation/Immunology Cancer

RIP1 kinase inhibitor 9 (compound SY-1) is a selective RIP kinase inhibitor. RIP1 kinase inhibitor 9 effectively suppresses the central inflammatory response induced by epilepsy. RIP1 kinase inhibitor 9 inhibits Z-VAD-FMK (HY-16658B)-induced necroptosis in HT-29 cells with an EC50 of 7.04 nM .
loading...
    loading...
Cat. No.: HY-N7175
CAS No.: 86363-50-0
Synonyms: 9,11-Dehydroergosterol peroxide; 9(11)-DHEP
5,8-Epidioxyergosta-6,9(11),22-trien-3-ol (9,11-Dehydroergosterol peroxide), an important steroid from medicinal mushroom, exerts antitumor activity in several tumor types. 5,8-Epidioxyergosta-6,9(11),22-trien-3-ol inhibits HT29 cell growth by inducing CDKN1A expression, thus causing cell cycle arrest and apoptosis .
loading...
    loading...
Cat. No.: HY-172617
CAS No.: 877810-03-2
Research Areas:  

Cancer

APD-94 is a dual inhibitor targeting tubulin and Bmi-1. APD-94 interfers tubulin normal polymerization. APD-94 suppresses the expression of Bmi-1. APD-94 causes cell cycle arrest at the G2/M phase in cancer cells and induces apoptosis, thus inhibiting cancer cell proliferation. APD-94 represses the growth of HT29 cell xenografts in NOD/SCID mice. APD-94 can be used for colorectal cancer study .
loading...
    loading...
Cat. No.: HY-125387
CAS No.: 1628439-59-7
Target:  

Src

Research Areas:  

Inflammation/Immunology

TOP1210 is a narrow-spectrum tyrosine kinase inhibitor with potent inhibitory activity against P38α, Src, and Syk kinases. TOP1210 effectively reduced proinflammatory cytokines released by peripheral blood monocytes, primary macrophages, HT29 cells, inflammatory cells in ulcerative colitis (UC) biopsies, and myofibroblasts isolated from inflamed colonic UC mucosa. TOP1210 showed significant anti-inflammatory effects in cell experiments and UC biopsies, superior to some selective kinase inhibitors. The multi-kinase inhibition of TOP1210 provides the possibility of obtaining a wider range of therapeutic effects, especially in the regulation of autoimmune responses .
loading...
    loading...
Cat. No.: HY-N12820
CAS No.: 863767-80-0
3-O-6-Deoxy-3-O-methyl-β-D-allopyranosyl-(1→4)-β-D-oleandropyranosyl-tenacigenin C can be isolated from Alocasia cucullata (Lour.) G. Don. 3-O-6-Deoxy-3-O-methyl-β-D-allopyranosyl-(1→4)-β-D-oleandropyranosyl-tenacigenin C has moderate tumor cells inhibitory activity against MGC-803 and HT-29 cells with IC50 values of 45.6 and 28.4 μg/mL, respectively .
loading...
    loading...